Since reduction of the non-classical CD14 + CD16 + monocyte subset characterizes peripheral blood from active RA patients [33], these results indicate that Upa restores the balance of monocyte subsets found in healthy individuals, a finding that agrees with the known therapeutic action of JAKi (Fig. 1A–B). Here, FCGR3A is linked to rheumatoid arthritis.